PedAM
Pediatric Disease Annotations & Medicines
| Disease | myocardial infarction |
| Phenotype | C0010068|coronary disease |
| Sentences | 9 |
| PubMedID- 20617041 | Future efforts might explore air pollution as a trigger for myocardial infarction in patients with established coronary disease and perhaps focus on fatal events occurring out of hospital which seem to be particularly susceptible to air pollution increases. |
| PubMedID- 26011638 | Outcomes after multivessel or culprit-vessel intervention for st-elevation myocardial infarction in patients with multivessel coronary disease: a bayesian cross-design meta-analysis. |
| PubMedID- 22855086 | Because little is known about spontaneous coronary artery dissection in this population of women, recommendations for treatment are the same as for treatment of acute myocardial infarction associated with atherosclerotic coronary disease. |
| PubMedID- 25814353 | Background: the best approach for revascularization of multi-vessel coronary disease in patients with st-elevation myocardial infarction (stemi) undergoing primary percutaneous coronary intervention (pci) is controversial. |
| PubMedID- 22442638 | The prove-it study found that intensive treatment with atorvastatin 80 mg was better than pravastatin 40 mg at preventing death and major cardiovascular events following acs.54 the a to z study which compared 40 mg and 80 mg of simvastatin demonstrated a benefit which did not reach statistical significance, while the miracl (myocardial ischaemia reduction with aggressive cholesterol lowering) study showed that early intensive treatment with atorvastatin 80 mg after acs led to a 16% reduction in death, acute mi, unstable angina and cardiac arrest, compared with placebo.55 meta-analyses of intensive statin trials have also shown that intensive treatment provides benefit above lower intensity treatment in prevention of myocardial infarction and strokes in patients with known coronary disease irrespective of the baseline ldl-c. the centaurus (comparison of the effects noted in the apob:apoa-1 ratio using rosuvastatin or atorvastatin in patients with acute coronary syndrome) study showed that 20 mg rosuvastatin produced similar changes in apob:apoa-1 ratio at 3 months when compared with atorvastatin 80 mg. previous studies have identified apob:apoa-1 ratio as an important predictor of myocardial infarction. |
| PubMedID- 26282725 | Safety and efficacy of staged percutaneous coronary intervention during index admission for st-elevation myocardial infarction with multivessel coronary disease (insights from the university of ottawa heart institute stemi registry). |
| PubMedID- 21651821 | This myocardial injury has many similarities to the traditional myocardial infarction attributed to ischemic coronary disease [17]. |
| PubMedID- 24481100 | Takotsubo cardiomyopathy (tc) is a syndrome characterized by transient left ventricular apical ballooning associated with electrocardiogram changes and mimicking acute myocardial infarction in patients without significant coronary disease on angiography. |
| PubMedID- 26089843 | Comparison of clinical outcomes between culprit vessel only and multivessel percutaneous coronary intervention for st-segment elevation myocardial infarction patients with multivessel coronary diseases. |
Page: 1